|
|
|
|
A more recent version of this article appeared on August 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 26, 2007
Revised on May 1, 2007
Accepted on May 29, 2007
Departments of *Pediatrics and
Microbiology, Mount Sinai School of Medicine, New York, NY 10029
Monitoring Editor: Adam Linstedt
HSV harnesses cellular calcium signaling pathways to facilitate viral entry. Confocal microscopy and small interfering RNA (siRNA) were used to identify the source of the calcium and dissect the requisite viral-cell interactions. Binding of HSV to human epithelial cells induced no calcium response, but shifting the cells to temperatures permissive for penetration triggered increases in plasma membrane calcium followed by a global release of intracellular calcium. Transfection with siRNA targeting the proteoglycan, syndecan-2, blocked viral binding and abrogated any calcium response. Transfection with siRNA targeting nectin-1, a glycoprotein D receptor, also prevented both membrane and intracellular calcium responses. In contrast, the membrane response was preserved following transfection with siRNA targeting integrin
v, a novel glycoprotein H receptor. The membrane response, however, was not sufficient for viral entry which required interactions with integrin
V and release of inositol-triphosphate receptor-dependent intracellular calcium stores. Thus, calcium plays a critical, complex role in HSV entry.